Literature DB >> 8398284

Survival data relating to the use of goserelin depot in the treatment of premenopausal advanced breast cancer.

R W Blamey, W Jonat, M Kaufmann, A R Bianco, M Namer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8398284     DOI： 10.1016/0959-8049(93)90031-a

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  4 in total

Review 1.  Clinical pharmacokinetics of goserelin.

Authors:  I D Cockshott
Journal:  Clin Pharmacokinet       Date:  2000-07       Impact factor: 6.447

Review 2.  Goserelin (Zoladex)--its role in early breast cancer in pre- and perimenopausal women.

Authors:  W Jonat
Journal:  Br J Cancer       Date:  2001-11       Impact factor: 7.640

3.  Luteinizing hormone-releasing hormone analogues--the rationale for adjuvant use in premenopausal women with early breast cancer.

Authors:  W Jonat
Journal:  Br J Cancer       Date:  1998-09       Impact factor: 7.640

4.  Luteinizing hormone-releasing hormone analogues in early breast cancer: updated status of ongoing clinical trials.

Authors:  M Kaufmann
Journal:  Br J Cancer       Date:  1998-09       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.